From Casetext: Smarter Legal Research

Classen Immunotherapies, Inc. v. Elan Pharms., Inc.

United States Court of Appeals for the Federal Circuit
Oct 17, 2017
2017-1033 (Fed. Cir. Oct. 17, 2017)

Opinion

2017-1033

10-17-2017

CLASSEN IMMUNOTHERAPIES, INC., A MARYLAND CORPORATION, Plaintiff-Appellant JOHN BARTHELOW CLASSEN, Counterclaim Defendant v. ELAN PHARMACEUTICALS, INC., A DELAWARE CORPORATION, Defendant/Counterclaimant-Appellee

JOSEPH J. ZITO, DNL ZITO, Washington, DC, argued for plaintiff-appellant. Also represented by LUIZ FELIPE V S C DE OLIVEIRA. JAMES B. MONROE, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC, argued for defendant/counterclaimant-appellee. Also represented by PAUL WILLIAM BROWNING.


NOTE: This disposition is nonprecedential. Appeal from the United States District Court for the District of Maryland in No. 1:04-cv-03521-RDB, Judge Richard D. Bennett.

JUDGMENT

JOSEPH J. ZITO, DNL ZITO, Washington, DC, argued for plaintiff-appellant. Also represented by LUIZ FELIPE V S C DE OLIVEIRA. JAMES B. MONROE, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC, argued for defendant/counterclaimant-appellee. Also represented by PAUL WILLIAM BROWNING. THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (PROST, Chief Judge, LOURIE and TARANTO, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT October 17, 2017

Date

/s/ Peter R. Marksteiner

Peter R. Marksteiner

Clerk of Court


Summaries of

Classen Immunotherapies, Inc. v. Elan Pharms., Inc.

United States Court of Appeals for the Federal Circuit
Oct 17, 2017
2017-1033 (Fed. Cir. Oct. 17, 2017)
Case details for

Classen Immunotherapies, Inc. v. Elan Pharms., Inc.

Case Details

Full title:CLASSEN IMMUNOTHERAPIES, INC., A MARYLAND CORPORATION, Plaintiff-Appellant…

Court:United States Court of Appeals for the Federal Circuit

Date published: Oct 17, 2017

Citations

2017-1033 (Fed. Cir. Oct. 17, 2017)